- BH Outpatient/PH/IOP Value Set with BH Outpatient/PH/IOP POS Value Set and Schizophrenia Value Set - ED Value Set with Schizophrenia Value Set - BH ED Value Set with ED POS Value Set and Schizophrenia Value Set - BH Stand Alone Nonacute Inpatient Value Set with Schizophrenia Value Set - BH Nonacute Inpatient Value Set with BH Nonacute Inpatient POS Value Set and Schizophrenia Value Set - At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED, or nonacute inpatient setting, on different dates of service, with any diagnosis of bipolar disorder. Any two of the following code combinations meet criteria: - BH Stand Alone Outpatient/PH/IOP Value Set with Bipolar Disorder Value Set - BH Stand Alone Outpatient/PH/IOP Value Set with Other Bipolar Disorder Value Set - BH Outpatient/PH/IOP Value Set with BH Outpatient/PH/IOP POS Value Set and Bipolar Disorder Value Set - BH Outpatient/PH/IOP Value Set with BH Outpatient/PH/IOP POS Value Set and Other Bipolar Disorder Value Set - ED Value Set with Bipolar Disorder Value Set - ED Value Set with Other Bipolar Disorder Value Set - BH ED Value Set with ED POS Value Set and Bipolar Disorder Value Set - BH ED Value Set with ED POS Value Set and Other Bipolar Disorder Value Set - BH Stand Alone Nonacute Inpatient Value Set with Bipolar Disorder Value Set - BH Stand Alone Nonacute Inpatient Value Set with Other Bipolar Disorder Value Set - BH Nonacute Inpatient Value Set with BH Nonacute Inpatient POS Value Set and Bipolar Disorder Value Set - BH Nonacute Inpatient Value Set with BH Nonacute Inpatient POS Value Set and Other Bipolar Disorder Value Set Abilify Abilify Discmelt Abilify Maintena Aripiprazole Aristada Chlorpromazine Hydrochloride Clozapine Clozaril Compazine Fanapt FazaClo Fluoxetine Hydrochloride-Olanzapine Fluphenazine Decanoate Fluphenazine Hydrochloride Geodon Haldol Decanoate Haloperidol Haloperidol Decanoate Haloperidol Lactate
HPL: 0.6892 MPL: 0.4881 National Quality Compass 2016 - All LOBs: Average (90th and 25th percentiles) Unit of Measurement for Payer Type Unit: Individuals Measure will be reported for all-payer, medicaid, and uninsured unless an exception is requested and approved through the RHP Plan Update. Baseline Details Shortened baseline measurement period is allowed with justification submitted in the RHP Plan Update. Measure is eligible for a baseline numerator of 0 per PFM Section VI.22.b.i (page 24). If approved for a baseline of zero, the DY7 goal will be 61.69% and DY8 goal of 62.41%. Denominator Description Women 16 to 24 years of age who are sexually active and who had a visit in the measurement period Exclusions: Women who are only eligible for the initial population due to a pregnancy test and who had an x-ray or an order for a specified medication within 7 days of the pregnancy test. Exclude patients who were in hospice care during the measurement year. Denominator Inclusions AND: Age>= 16 year(s) at: "Measurement Period" AND: Age< 24 year(s) at: "Measurement Period" AND: "Patient Characteristic Sex: Female" AND: Union of: "Encounter, Performed: Office Visit" "Encounter, Performed: Face-to-Face Interaction" "Encounter, Performed: Preventive Care Services - Established Office Visit, 18 and Up" "Encounter, Performed: Preventive Care Services-Initial Office Visit, 18 and Up" "Encounter, Performed: Preventive Care - Established Office Visit, 0 to 17" "Encounter, Performed: Preventive Care- Initial Office Visit, 0 to 17" "Encounter, Performed: Home Healthcare Services" during "Measurement Period" AND: OR: "Assessment, Performed: Sexually Active (result: Yes Response)" starts before end of "Measurement Period" OR: Union of: "Diagnosis: Other Female Reproductive Conditions" "Diagnosis: Genital Herpes"